Back to UBS Group AG UBS Group AG

LITSLITS
Showing 8 of 13 quarters

Position history for UBS Group AGUBS Group AG's holdings in MEI PHARMA INC

Yes. Ubs holds 91,141 shares of LITS (Mei Pharma), worth $84,032, as of its Q2 2026 13F filing. It increased the position by 39,791 shares (+77.5%) from Q1 2026. Ubs has held LITS since Q2 2023, across 13 quarterly 13F filings.

Current Value

$84,032

Current Shares

91,141

Total Value Change

+$47,330

Total Shares Change

+78,263

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
91,141
+77.5%
$84,0320.0%$0.92
22
2026-Q1
Decreased
51,350
-58.9%
$59,5660.0%$1.16
0
2025-Q4
Decreased
125,048
-84.3%
$165,0630.0%$1.32
0
2025-Q3
Increased
797,118
+9559.7%
$1.9M0.0%$2.42
42
2025-Q2
Increased
8,252
+28.0%
$20,3820.0%$2.47
16
2025-Q1
Decreased
6,445
-42.3%
$14,1150.0%$2.19
0
2024-Q4
Decreased
11,161
-13.3%
$27,4560.0%$2.46
0
2024-Q3
Increased
12,878
+59.0%
$36,7020.0%$2.85
19

Other major holders of LITS: CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used